Session Details

P006 Skin of Color Primer

Fri, Aug 2, 1:00 PM - 4:00 PM
608
3 CME Available 3 Hour Parallel
View Map

DESCRIPTION

This session will provide a comprehensive and concise high-yield overview of common conditions seen in skin of color. Skin, hair, and nail conditions which either uniquely affect skin of color populations or which present differently in skin of color will be discussed. This will include inflammatory, neoplastic, pigmentary, and alopecic conditions and other high-yield common skin of color conditions. Discussion will include updates in pathogenesis, along with evaluation and management considerations. Complementary and alternative treatment approaches will also be discussed. Presentations will include unique cultural considerations and cultural competency in the delivery of care to diverse populations.

LEARNING OBJECTIVES

1.

Improve diagnosing of dermatologic conditions in skin of color.

2.

Select safe and effective treatment options for various conditions across diverse populations.

3.

Identify cultural competency considerations in taking care of patients of color.

SCHEDULE

8:00 PM

Introduction and Inflammatory Cutaneous Conditions in Skin of Color

Nada Elbuluk, MD, FAAD

8:25 PM

Pigmentary Disorders and Miscellaneous Conditions in Skin of Color

Tasneem Mohammad, MD, FAAD

8:50 PM

Q&A

Nada Elbuluk, MD, FAAD, Tasneem Mohammad, MD, FAAD

9:00 PM

Nonscarring alopecias and hair care in SOC

Tiffany Mayo, MD, FAAD

9:25 PM

Scarring alopecias in SOC

Susan C. Taylor, MD, FAAD

9:50 PM

Q&A

Tiffany Mayo, MD, FAAD, Susan C. Taylor, MD, FAAD

10:00 PM

Skin Cancer in SOC

Rebecca Vasquez, MD, FAAD

10:30 PM

Complementary and Alternative Therapies in Skin of Color

Raja Sivamani, MD, FAAD

10:50 PM

Q&A

Raja Sivamani, MD, FAAD, Rebecca Vasquez, MD, FAAD

SPEAKERS

Nada Elbuluk, MD, FAAD

Nada Elbuluk, MD, FAAD

Tiffany Mayo, MD, FAAD

Tiffany Mayo, MD, FAAD

Tasneem Mohammad, MD, FAAD

Tasneem Mohammad, MD, FAAD

Raja Sivamani, MD, FAAD

Raja Sivamani, MD, FAAD

Integrative Skin Science and Research

Susan C. Taylor, MD, FAAD

Susan C. Taylor, MD, FAAD

Bernett L. Johnson Endowed Professor of Dermatology, Perelman School of Medicine, University of Pennsylvania

Rebecca Vasquez, MD, FAAD

Rebecca Vasquez, MD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Nada Elbuluk, MD, FAAD

AbbVie – Advisory Board(Fees); Avita – Consultant(Fees); Beiersdorf – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Speaker(Fees); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Dior – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Fees); Galderma Laboratories, L.P. – Advisory Board(Fees); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Advisory Board(Fees), Consultant(Fees); Janssen Biotech – Advisory Board(Fees); L'Oreal USA Inc. – Advisory Board(Fees); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Fees); McGraw-Hill Companies – Advisory Board(Fees), Other(Other Financial Benefit); Medscape – Speaker(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); The Skin of Color Society – Board of Directors(No Compensation Received); VisualDx – Consultant(Fees), Consultant(Stock Options); Women's Dermatologic Society – Board of Directors(No Compensation Received);

Tiffany Mayo, MD, FAAD

AbbVie – Consultant (1099 relationship)(Honoraria); Acelyrin – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Investigator(Grants/Research Funding); ChemoCentryx – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Galderma – Investigator(Grants/Research Funding); Incyte – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Procter & Gamble Company – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);

Tasneem Mohammad, MD, FAAD

Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); atheneum – Consultant(Honoraria), Consultant (1099 relationship)(Fees); Avita – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Beiersdorf – Consultant (1099 relationship)(Fees); Beiersdorf, Inc. – Speaker(Honoraria); Clinuvel – Investigator(Grants/Research Funding); Disc Medicine – Investigator(Grants/Research Funding); Ferndale Laboratories, Inc. – Advisory Board(Honoraria); Guidepoint Global, LLC – Consultant(Honoraria); Immune Tolerance Network – Investigator(Grants/Research Funding); Incyte – Advisory Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); KeyQuest Health – Consultant (1099 relationship)(Fees); Medscape – Speaker/Faculty Education(Honoraria); Mitsubishi Tanabe Pharma Corporation – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); polaris health – Speaker/Faculty Education(Honoraria); Research America – Consultant(Honoraria); TheraVida – Consultant(Fees); Third Bridge – Consultant (1099 relationship)(Honoraria); Unigen – Investigator(Grants/Research Funding);

Raja Sivamani, MD, FAAD

AbbVie – Speaker(Honoraria); Almirall – Speaker(Honoraria); Arbonne – Advisory Board(Fees); Bristol Myers Squibb – Speaker(Honoraria); Burt's Bees – Consultant(Fees); Codex Labs – Advisory Board(Fees); Eli Lilly – Speaker(Honoraria); Image Skincare – Advisory Board(Honoraria); Incyte Corporation – Speaker(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Speaker(Honoraria); Novartis – Advisory Board(Honoraria); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Trace Minerals – Advisory Board(Honoraria);

Susan C. Taylor, MD, FAAD

AbbVie – Advisory Board(Honoraria); Allergan Aesthetics – Investigator(Grants/Research Funding); Arcutis, Inc. – Consultant(Honoraria); Armis Biopharma, Inc. – Advisory Board(No Compensation Received); Avita Medical – Advisory Board(Honoraria); Beiersdorf, Inc. – Advisory Board(No Compensation Received), Consultant(Honoraria), Speaker/Faculty Education(Honoraria); Biorez, Inc. – Advisory Board(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria); Cara Therapeutics – Consultant(Honoraria); Catalyst Medical Education LLC – Speaker/Faculty Education(Honoraria); CME Outfitters – Speaker/Faculty Education(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Croma-Pharma GmbH Austria – Investigator(Grants/Research Funding); Dermsquared – Speaker/Faculty Education(Honoraria); Dior – Consultant(Honoraria); Eli Lilly and Company – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); EPI Health – Advisory Board(Honoraria); Estee Lauder – Advisory Board(Honoraria); Evolus, Inc. – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Advisory Board(Honoraria); GloGetter, Inc – Advisory Board(No Compensation Received); HMP Global – Speaker/Faculty Education(Honoraria); Hugel – Advisory Board(Honoraria); Incyte – Advisory Board(Honoraria); Johnson & Johnson Innovative Medicine – Advisory Board(No Compensation Received); L'Oreal USA Inc. – Advisory Board(No Compensation Received); LearnSkin – Speaker/Faculty Education(Honoraria); Medscape – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); MJH Life Sciences – Speaker/Faculty Education(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Piction Health – Advisory Board(No Compensation Received); Sanofi – Consultant(Honoraria); Scientis – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria); Vichy Laboratoires – Advisory Board(Honoraria);

Rebecca Vasquez, MD, FAAD

No financial relationships exist with ineligible companies.